Richardson Linda M — SEC insider filings
SEC reporting owner CIK 1595064. 18 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2021-02-17 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) | EVP & Chief Commercial Officer | 16 | — | — | 28 |
| Altimmune, Inc. (ALT) | Chief Commercial Officer | 2 | — | — | 5 |
Insider filings — Richardson Linda M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 24,000 @ $0 · Tax withholding (F): 6,826 @ $3.24 · Option exercise (M): 24,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 278,000 (derivative) @ $0 · Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2023-11-13 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Code (U): 16,706 @ $19 · Disposition to issuer (D): 26,585 @ $19 · Disposition to issuer (D): 17,600 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 3,912 (derivative) · Disposition to issuer (D): 8,368 (derivative) · +4 more | EDGAR |
| 2023-02-16 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 386 @ $21.21 | EDGAR |
| 2023-01-31 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Grant/award (A): 12,200 @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 1,600 @ $12.37 | EDGAR |
| 2022-09-06 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 597 @ $18.06 | EDGAR |
| 2022-08-17 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 124 @ $18.19 | EDGAR |
| 2022-05-17 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 124 @ $17.88 | EDGAR |
| 2022-02-17 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 171 @ $15.93 | EDGAR |
| 2022-02-15 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 529 @ $14.85 | EDGAR |
| 2022-01-31 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Grant/award (A): 10,300 @ $0 · Grant/award (A): 17,600 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 1,211 @ $16.29 | EDGAR |
| 2021-11-17 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 171 @ $17.67 | EDGAR |
| 2021-09-03 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 820 @ $15.05 | EDGAR |
| 2021-08-16 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 171 @ $14.92 | EDGAR |
| 2021-05-17 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Tax withholding (F): 171 @ $18.15 | EDGAR |
| 2021-02-17 | 4 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) | Grant/award (A): 5,531 @ $0 · Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1595064 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs